229 reports of this reaction
2.3% of all VONOPRAZAN FUMARATE reports
#6 most reported adverse reaction
MALAISE is the #6 most commonly reported adverse reaction for VONOPRAZAN FUMARATE. There are 229 FDA adverse event reports linking VONOPRAZAN FUMARATE to MALAISE. This represents approximately 2.3% of all 9,763 adverse event reports for this drug.
Patients taking VONOPRAZAN FUMARATE who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MALAISE is a less commonly reported adverse event for VONOPRAZAN FUMARATE, but still significant enough to appear in the safety profile.
In addition to malaise, the following adverse reactions have been reported for VONOPRAZAN FUMARATE:
The following drugs have also been linked to malaise in FDA adverse event reports:
MALAISE has been reported as an adverse event in 229 FDA reports for VONOPRAZAN FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MALAISE accounts for approximately 2.3% of all adverse event reports for VONOPRAZAN FUMARATE, making it a notable side effect.
If you experience malaise while taking VONOPRAZAN FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.